Sodium Channel Subunit Beta-4 (ISO Form 1) as a Drug Target and Biomarker

Target Name: SCN4B

NCBI ID: G6330

SCN4B

Sodium Channel Subunit Beta-4 (ISO Form 1) as a Drug Target and Biomarker

Introduction

Sodium channel subunit beta-4 (SCN4B) is a protein that plays a crucial role in the regulation of sodium (Na+) channels, which are responsible for transmitting electrical signals in and out of cells. The function of SCN4B is to form a complex with the ion channel pore complex protein (CAPN4), allowing it to regulate the opening and closing of the channel. Mutations in the SCN4B gene have been linked to various neurological and cardiac disorders, making it an attractive drug target and a potential biomarker.

Drug Development

Several drugs have been developed to target SCN4B, including natural compounds, small molecules, and peptides. One of the most promising natural compounds is curcumin, which is an antioxidant and anti-inflammatory compound found in turmeric, a spice commonly used in Indian cuisine. Curcumin has been shown to have neuroprotective properties and to modulate SCN4B-CAPN4 interactions, making it a potential drug candidate for the treatment of neurological disorders.

Another small molecule, N-Acetyl-L-Tyrosine (NAT), has also been shown to interact with SCN4B and CAPN4. NAT is an amino acid that has been shown to modulate the activity of various ion channels, including SCN4B. Studies have suggested that NAT may be a useful drug candidate for the treatment of neurological disorders caused by disruptions in SCN4B function.

Peptides also have been identified as potential SCN4B drug targets. One of these peptides, called P10, is a highly conserved protein that shares sequence similarities with SCN4B. P10 has been shown to interact with CAPN4 and may be a useful biomarker for the diagnosis and monitoring of SCN4B-related disorders.

Mechanisms of Action

The mechanisms of action of SCN4B and its potential drug targets are still being explored. However, several studies have identified key features of SCN4B that are involved in its function. One of these features is the presence of a hypervariable region (HVR) in the SCN4B gene. HVRs are regions of the gene that can vary in their sequence, and they are often involved in protein-protein interactions.

The HVR region of SCN4B is involved in the formation of the SCN4B-CAPN4 complex. Studies have shown that the HVR region plays a critical role in the stability and functional relevance of this complex. Mutations in the HVR region have been linked to decreased SCN4B activity and disruptions in the regulation of sodium channels.

Another key feature of SCN4B is its role in cell signaling. SCN4B is involved in the regulation of a variety of cellular processes, including cell signaling, cytoskeletal organization, and intracellular signaling. Its activity is regulated by various chemical and physical factors, including temperature, pH, and ligand concentration.

Targeting SCN4B

Several techniques have been used to target SCN4B, including genetic modification, protein knockdown, and small molecule inhibition. One of the most effective strategies for targeting SCN4B is the use of small molecules that can modulate its activity.

curcumin, natural compoundN-Acetyl-L-Tyrosine (NAT), and P10, a peptide, have been shown to interact with SCN4B and CAPN4, respectively, and may be useful drug candidates. Additionally, some studies have shown that other small molecules, Such as 尾-endotoxins and heavy metals, can also interact with SCN4B and CAPN4 and may be potential drug targets.

Conclusion

SCN4B is a protein that plays a critical role in the regulation of sodium channels and is involved in a variety of cellular processes. Its activity is regulated by various factors, including temperature, pH, and ligand concentration. Several natural compounds, small molecules, and peptides have been shown to interact with SCN4B and its potential drug targets. Further research is needed to fully understand the mechanisms of action of SCN4B and its potential as a drug target.

Protein Name: Sodium Voltage-gated Channel Beta Subunit 4

Functions: Modulates channel gating kinetics. Causes negative shifts in the voltage dependence of activation of certain alpha sodium channels, but does not affect the voltage dependence of inactivation. Modulates the susceptibility of the sodium channel to inhibition by toxic peptides from spider, scorpion, wasp and sea anemone venom

The "SCN4B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCN4B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets